CategoryMedical & Pharma
Asia Pacific Breast Cancer Summit (APBCS)
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Asia Pacific Breast Cancer Summit (APBCS) — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
Asia Pacific Breast Cancer Summit (APBCS)
The Asia Pacific Breast Cancer Summit (APBCS) is a regional medical and clinical conference focused on advancing breast cancer prevention, early detection, treatment, and care pathways across the Asia-Pacific landscape. The summit typically brings together multidisciplinary stakeholders—healthcare professionals, researchers, clinicians, academic and hospital leaders, industry partners, and public health contributors—to support knowledge exchange and collaboration on breast cancer priorities relevant to the region.
Event Snapshot
- Event name: Asia Pacific Breast Cancer Summit (APBCS)
- Official website: https://apbcs.org/
- Dates:
- Venue:
- City & Country:
- Primary focus area: Breast cancer awareness, clinical practice, research, and healthcare collaboration in the Asia-Pacific region
What This Summit Is For
APBCS is designed to act as a high-signal platform for stakeholders who influence breast cancer outcomes. The summit format generally supports:
- Clinical and translational knowledge sharing across prevention, diagnosis, and treatment standards.
- Cross-institution collaboration between hospitals, research groups, and academic centers.
- Regional healthcare pathway dialogue to address differences in screening access, late presentation, and treatment delivery models across countries in Asia-Pacific.
- Industry–academia engagement to align on innovations that can improve patient care, including therapeutic advances and supportive care approaches.
Why the Asia-Pacific Context Matters
Breast cancer burden and outcomes vary across Asia-Pacific due to differences in screening programs, awareness levels, diagnostic capacity, treatment access, and survivorship support. A summit dedicated to this region helps participants benchmark practices, identify gaps, and explore initiatives that can improve early detection and patient outcomes within local realities.
Who Typically Attends (Buyer/Attendee Relevance)
While exact attendee composition can vary by edition, APBCS commonly attracts decision-influencing and budget-influencing participants such as:
- Oncology leadership (oncologists, breast surgeons, medical directors)
- Diagnostic and screening stakeholders (radiology, pathology, imaging and breast health teams)
- Research and academic representatives (university faculty, clinical researchers, research coordinators)
- Hospital and healthcare administrators (clinical operations leaders, service line leaders)
- Public health and policy contributors supporting screening and awareness efforts
- Industry partners across pharmaceuticals, diagnostics, oncology care delivery solutions, and related healthcare innovation groups
Buyer Engagement Angle (How We Position This Event)
We position APBCS as a high-relevance event for collecting attendee and stakeholder intelligence in the breast cancer and oncology ecosystem—especially among Asia-Pacific decision-makers who influence clinical adoption, research collaboration, and healthcare program implementation.
For audience-list research and deep event analysis, we treat the summit as a specialty medical conference where the highest-value contacts typically sit in oncology leadership, breast health programs, research networks, hospital clinical governance, and oncology-focused industry teams.
Important Note About Dates and Venue
The provided official website text was only a redirection message and did not include verifiable information about dates, venue, or city/country. To avoid contradictions, we are leaving those fields blank rather than guessing.
Information We Can Confirm Next
If we receive the official page content that contains the event schedule details (or a publicly visible event announcement section), we can update this description with the exact dates, venue, and city/country.
Data sheet
Asia Pacific Breast Cancer Summit (APBCS) – Event Attendee & Buyer Profile Analysis
Event Date: 22–24 January 2027
Location: Singapore, Singapore
Event Status: Upcoming
Research Date: 30 June 2026
Event Overview
| Event Name | Asia Pacific Breast Cancer Summit (APBCS) |
| Event Date | 22–24 January 2027 |
| Event Status | Upcoming |
| Venue | Not publicly confirmed in the available official website text |
| City | Singapore |
| State / Region | Singapore |
| Country | Singapore |
| Organizer | Not publicly confirmed in the available official website text |
| Official Event Website | apbcs.org |
| Event Type | Medical summit / healthcare conference |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Wellness, Health & Fitness; Science & Research; IT & Technology |
| Audience Reach | Likely regional with Asia-Pacific draw; potential international specialist participation |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for current edition; official website content available to review did not disclose attendance or venue details |
| Main Purpose of Event | To convene breast cancer clinicians, researchers, pharmaceutical stakeholders, diagnostics stakeholders, and healthcare leaders for scientific exchange, treatment updates, and collaboration |
About the Event
The Asia Pacific Breast Cancer Summit (APBCS) is a specialist healthcare event centered on breast cancer diagnosis, treatment, research, and patient-care innovation. Based on the event title and official website presence, it is positioned as a focused summit for clinicians, researchers, healthcare institutions, and life-science stakeholders with direct involvement in breast cancer care.
The summit is relevant for scientific education, clinical collaboration, pharma engagement, diagnostics adoption, and healthcare partnership development across the Asia-Pacific region. It is especially useful for organizations selling oncology-related products, services, technologies, and research solutions into hospitals, cancer centers, labs, and medical networks.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Oncology clinicians and medical directors | Cancer hospitals, tertiary care hospitals, specialist oncology centers | Clinical decision-making and protocol influence | High relevance for therapies, diagnostics, imaging, clinical workflow tools, and education |
| Breast surgeons and surgical department leaders | Hospitals, private surgical groups, cancer institutes | Product evaluation and procedure adoption | Relevant for surgical devices, biopsy tools, imaging, and perioperative products |
| Radiologists and imaging directors | Diagnostic imaging centers, hospitals, academic medical centers | Technology selection and screening pathway influence | Strong fit for imaging systems, AI diagnostics, PACS, workflow software |
| Pathologists and laboratory leaders | Reference labs, hospital labs, molecular diagnostics facilities | Testing and assay purchasing influence | Relevant for pathology systems, biomarkers, lab automation, consumables |
| Medical oncologists and hematology-oncology specialists | Cancer centers, university hospitals, specialty clinics | Treatment pathway influence and trial referral | High relevance for drugs, companion diagnostics, research services, clinical tools |
| Nursing and patient support leaders | Hospitals, oncology wards, care-navigation groups | Implementation and patient-experience influence | Relevant for patient support services, education, adherence, symptom-management solutions |
| Clinical researchers and trial operations teams | Universities, research hospitals, CROs, biotech firms | Study design, trial execution, vendor selection | Relevant for data platforms, recruitment, CRO services, biomarker and trial support |
| Pharmaceutical and biotech business leaders | Pharma companies, biotech companies, medical affairs teams | Partnerships, commercialization, KOL engagement | Relevant for licensing, clinical collaboration, med affairs tools, evidence generation |
| Healthcare procurement and hospital operations teams | Public hospitals, private hospital chains, group purchasing organizations | Vendor shortlisting and purchasing | Relevant for diagnostics, devices, IT, consumables, and clinical services |
| Patient advocacy and association leaders | Breast cancer foundations, advocacy groups, nonprofit organizations | Influence on awareness, education, and program partnerships | Relevant for educational partnerships, sponsorships, outreach campaigns, patient resources |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: Singapore | Local hospitals, research institutes, med-tech firms, pharma offices | High | Singapore is a regional healthcare and life-sciences hub |
| Host state / region: Singapore | National healthcare networks and biomedical institutions | High | Dense concentration of buyers and clinical decision-makers |
| Nearby business hubs | Malaysia, Indonesia, Thailand, Vietnam, Philippines, Hong Kong, India | Medium to High | Likely regional draw for clinical and commercial stakeholders |
| National reach | Singapore healthcare system, universities, research and private-sector life sciences | High | Likely strong attendance from local specialist networks |
| International reach | Regional APAC specialists, global pharma, research, diagnostics participants | Medium | Most likely to attract regional decision-makers rather than a mass consumer audience |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Primary: Regional | Best-fit classification | The summit is likely centered on Asia-Pacific clinical and commercial participation, with Singapore as a regional hub |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| National Cancer Centre Singapore | Cancer center / clinical buyer | High-fit institution for oncology education, treatment innovation, diagnostics, and research collaboration | nccs.com.sg | Director of Oncology, Medical Director, Procurement Manager, Research Director | Strong Market Fit, Attendance Not Confirmed |
| National University Hospital (NUH) | Hospital buyer | Major tertiary hospital likely to engage on oncology care, imaging, lab, and clinical research | nuh.com.sg | Head of Oncology, Imaging Director, Lab Manager, Purchasing Director | Strong Market Fit, Attendance Not Confirmed |
| Singapore General Hospital | Hospital buyer | Large public hospital with oncology, pathology, radiology, and research stakeholders | singhealth.com.sg | Department Chair, Clinical Lead, Procurement Head, Program Manager | Strong Market Fit, Attendance Not Confirmed |
| Agency for Science, Technology and Research (A*STAR) | Research institution | Relevant for translational research, biomarker work, and clinical innovation partnerships | astar.edu.sg | Research Director, Principal Investigator, Partnerships Manager, Grants Manager | Strong Market Fit, Attendance Not Confirmed |
| National University of Singapore | University / research buyer | Likely participant through medical school, biomedical, and research programs | nus.edu.sg | Professor, Lab Director, Research Administrator, Partnerships Lead | Strong Market Fit, Attendance Not Confirmed |
| Pfizer | Pharmaceutical buyer / sponsor-side stakeholder | Oncology portfolio and medical affairs functions align with breast cancer summit themes | pfizer.com | Medical Affairs Director, Oncology Brand Lead, Business Development Director | Strong Market Fit, Attendance Not Confirmed |
| Roche | Pharma / diagnostics buyer | Strong fit for oncology therapeutics, diagnostics, and companion diagnostic collaborations | roche.com | Medical Affairs Lead, Diagnostic Partner Manager, Oncology Director | Strong Market Fit, Attendance Not Confirmed |
| Novartis | Pharmaceutical buyer | Oncology-focused engagement around treatment strategy, evidence, and partnerships | novartis.com | Medical Director, Clinical Research Lead, Alliance Manager | Strong Market Fit, Attendance Not Confirmed |
| Merck | Pharmaceutical buyer | Relevant for oncology evidence-generation, medical education, and partnership discussions | merck.com | Medical Affairs Manager, Oncology Lead, Business Development Manager | Strong Market Fit, Attendance Not Confirmed |
| AbbVie | Pharmaceutical buyer | Potential oncology, medical affairs, and partnerships stakeholder | abbvie.com | Regional Medical Lead, Partnership Director, Scientific Communications Manager | Strong Market Fit, Attendance Not Confirmed |
| Siemens Healthineers | Medical imaging / diagnostics buyer | Relevant for imaging workflows, screening, diagnostics, and hospital partnerships | siemens-healthineers.com | Product Manager, Clinical Applications Lead, Sales Director | Strong Market Fit, Attendance Not Confirmed |
| Hologic | Women's health diagnostics / med-tech buyer | Breast screening and diagnostic technology aligns closely with the summit theme | hologic.com | Business Development Director, Product Manager, Clinical Specialist | Strong Market Fit, Attendance Not Confirmed |
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Medical Officer / Medical Director | Clinical leadership | C-level / Executive | Owns clinical direction, strategic partnerships, and adoption decisions |
| 2 | Head of Oncology / Oncology Director | Clinical services | Director | Key treatment and vendor-influence role for breast cancer programs |
| 3 | Procurement Manager / Purchasing Manager | Procurement | Manager | Influences purchasing of diagnostics, devices, services, and software |
| 4 | Head of Radiology / Imaging Director | Radiology | Director | Relevant for screening technology, workflow tools, and diagnostic systems |
| 5 | Laboratory Director / Pathology Head | Laboratory / pathology | Director | Relevant for biomarker, assay, and lab automation purchasing |
| 6 | Clinical Research Director / Trial Manager | Research / clinical trials | Director / Manager | Important for evidence-generation, partnerships, and vendor evaluation |
| 7 | Medical Affairs Director | Pharma / biotech | Director | Drives educational and scientific engagement, KOL strategy, and partnerships |
| 8 | Business Development Director / Partnership Manager | Commercial / alliances | Director / Manager | Targets collaboration, sponsorship, and commercialization opportunities |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Primary buyer base for oncology treatment and diagnostics | Hospitals, cancer centers, specialist clinics |
| 2 | Pharmaceuticals | Strong relevance to oncology treatment, medical affairs, and clinical collaboration | Drug development, launch, evidence, partnerships |
| 3 | Medical Devices | Relevant for imaging, biopsy, surgical, and monitoring solutions | Device sales and clinical adoption |
| 4 | Biotechnology | Relevant for biomarkers, trials, and translational research | R&D, clinical development, lab partnerships |
| 5 | Research | Fits academic and translational research participation | Clinical studies and publications |
| 6 | Health, Wellness & Fitness | Relevant where patient support, survivorship, and education programs matter | Patient engagement, education, adherence |
| 7 | Information Technology & Services | Relevant for oncology data systems, workflow, and digital care tools | Clinical software, analytics, interoperability |
| 8 | Market Research | Useful for patient insight, treatment adoption, and healthcare research | Survey, insights, and evidence services |
| 9 | Events Services | Relevant for sponsors, organizers, and association engagement | Summit partnerships and lead generation |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Unconfirmed | Official website text available for review did not disclose attendance | Use as a specialist summit with likely limited-to-medium attendance |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No verified exhibitor list in the provided official text | Likely not a large trade-show format |
| Buyer count | Not publicly confirmed | Unconfirmed | No official attendee breakdown available | Buyer intensity should be assessed from speaker and sponsor lists when published |
| Speaker count | Not publicly confirmed | Unconfirmed | Agenda/speaker page not available in the provided text | Speaker list would materially improve targeting accuracy |
| Historical attendance | Not publicly confirmed | Unavailable | No prior-year numbers were provided in the available source text | Attendance figure not publicly confirmed by the organizer. |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Oncology treatment | Better patient outcomes, updated protocols, and access to therapies | Medical education, KOL engagement, clinical evidence discussions | Pharma products, clinical services, educational content |
| Diagnostics and screening | Earlier detection, improved accuracy, workflow efficiency | Product demos, workflow optimization, procurement discussions | Imaging systems, biomarkers, lab tools, AI diagnostics |
| Clinical research | Trial enrollment, evidence generation, protocol support | Research collaboration and trial-support outreach | CRO services, eClinical tools, patient recruitment, data platforms |
| Patient care pathways | Care coordination and support services | Workflow and patient-navigation conversations | Patient support platforms, care management services |
| Medical education | Continuing education and best-practice updates | Sponsored sessions and targeted content distribution | Education grants, speaker programs, digital learning tools |
| Partnerships and commercialization | Access to expertise, channels, or clinical networks | Partner introductions and BD meetings | Licensing, distribution, co-marketing, research partnerships |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | Strong concentration of oncology, hospital, diagnostics, and pharma stakeholders |
| Decision-maker availability | High | Likely to include senior clinicians, medical directors, researchers, and commercial leaders |
| Data collection potential | Medium | Improves significantly once agenda, speakers, sponsors, or delegate lists are published |
| Apollo targeting potential | High | Clear industry and title mapping for hospitals, pharma, med-tech, and research institutions |
| Geographic targeting potential | High | Singapore plus APAC regional healthcare and life-sciences markets are clear target areas |
| Best outreach approach | High-touch, clinical-value messaging | Lead with outcomes, evidence, efficiency, and scientific credibility rather than generic event promotion |
| Overall lead quality | High | Strong specialist event with clear buyer personas, though current public attendance data is limited |
| Best use case | B2B attendee list building, hospital/pharma outreach, summit sponsorship targeting | Ideal for account-based prospecting and specialist healthcare lead generation |
| Limitations / risks | Venue, organizer, agenda, and attendance data not confirmed in accessible official text | Targeting accuracy will improve when the event publishes a speaker list, sponsor list, or registration page details |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Pharmaceuticals; Medical Devices; Biotechnology; Research; Information Technology & Services; Health, Wellness & Fitness | Capture the most relevant buyer universe for oncology and breast cancer-related solutions |
| Departments | Clinical, Medical Affairs, Research, Procurement, Operations, Business Development, Partnerships | Focus on roles that influence product, service, and partnership decisions |
| Seniority | Manager, Director, VP, CXO, Partner, Head | Prioritize decision-makers and budget holders |
| Job titles | Medical Director, Oncology Director, Head of Oncology, Procurement Manager, Director of Research, Clinical Trials Manager, Lab Director, Imaging Director, Medical Affairs Director, Business Development Director | High-intent titles aligned to summit content and purchasing influence |
| Geography | Singapore, Malaysia, Indonesia, Thailand, Philippines, Vietnam, Hong Kong, India, Australia | Regional APAC coverage with Singapore as the anchor market |
| Employee size | 51–200, 201–500, 501–1000, 1000+ | Targets established providers and institutions with buying power |
| Keywords | breast cancer, oncology, cancer center, oncology research, diagnostics, pathology, radiology, clinical trials, medical affairs, patient support | Improve relevance and reduce non-buyer noise |
| Company type | Hospitals, healthcare systems, research institutes, pharmaceutical firms, med-tech firms, diagnostics providers | Align with event’s clinical and commercial ecosystem |
Suggested Apollo Search Logic: (oncology OR breast cancer OR cancer center OR diagnostics OR pathology OR radiology) AND (Director OR Head OR Manager OR VP OR Chief) AND (Hospital & Health Care OR Pharmaceuticals OR Medical Devices OR Biotechnology OR Research) with geography filtered to Singapore and APAC priority markets.
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Asia Pacific Breast Cancer Summit official website | Official event website | Event identity and official web presence; available page text showed redirect notice only | Primary, but limited usable content in the provided capture |
| User-provided event details | Event brief | Event name, dates, city, and country | Useful input, not independently verified from the accessible official page text |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Asia Pacific Breast Cancer Summit (APBCS) — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds